Mednet Logo

How do you consider the role of probiotics for mucositis mitigation in patients receiving head and neck radiotherapy?

In light of the 4/2024 JCO publication by Peng et al., PMID 38215354
1 Answer
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Emory University
Answered on

This is a very interesting study and I am excited to see continued studies into symptom mitigation for definitive chemoRT.

I currently offer Ssk12 to my patients undergoing H+N RT (definitive or adjuvant). I see little potential downside as it is a relatively inexpensive intervention and they report...

Join for free or sign in to see the full answer